170 related articles for article (PubMed ID: 27481108)
1. Reduced potency of cytotoxic T lymphocytes from patients with high-risk myelodysplastic syndromes.
Sand K; Theorell J; Bruserud Ø; Bryceson YT; Kittang AO
Cancer Immunol Immunother; 2016 Sep; 65(9):1135-47. PubMed ID: 27481108
[TBL] [Abstract][Full Text] [Related]
2. In vitro deprivation of CD8(+)CD57(+)T cells promotes the malignant growth of bone marrow colony cells in patients with lower-risk myelodysplastic syndrome.
Zheng Z; Qianqiao Z; Qi H; Feng X; Chunkang C; Xiao L
Exp Hematol; 2010 Aug; 38(8):677-84. PubMed ID: 20394797
[TBL] [Abstract][Full Text] [Related]
3. Apoptotic cells and clonally expanded cytotoxic T cells in bone marrow trephines of patients with myelodysplastic syndrome.
Pülhorn H; Herrmann M; Harms H; Jung A; Baumann I
Histopathology; 2012 Aug; 61(2):200-11. PubMed ID: 22690734
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow CD3
Leone S; Rubino V; Palatucci AT; Giovazzino A; Carriero F; Cerciello G; Pane F; Ruggiero G; Terrazzano G
Eur J Haematol; 2022 Oct; 109(4):398-405. PubMed ID: 35775392
[TBL] [Abstract][Full Text] [Related]
5. Serum-free generation and quantification of functionally active Leukemia-derived DC is possible from malignant blasts in acute myeloid leukemia and myelodysplastic syndromes.
Kufner S; Fleischer RP; Kroell T; Schmid C; Zitzelsberger H; Salih H; de Valle F; Treder W; Schmetzer HM
Cancer Immunol Immunother; 2005 Oct; 54(10):953-70. PubMed ID: 15789235
[TBL] [Abstract][Full Text] [Related]
6. [Changes of natural kill cell in peripheral blood of patients with myelodysplastic syndrome].
Mi H; Fu R; Wang H; Qu W; Ruan E; Wang X; Wang G; Liu H; Wu Y; Song J; Xing L; Guan J; Li L; Jiang H; Zhang W; Yue L; Shao Z
Zhonghua Yi Xue Za Zhi; 2014 Mar; 94(10):737-41. PubMed ID: 24844955
[TBL] [Abstract][Full Text] [Related]
7. Defective cytotoxicity of T lymphocytes in myelodysplastic syndrome.
Cukrová V; Neuwirtová R; Dolezalová L; Belicková M; Bartůnková J; Jonásová A; Cermák J; Homolková H; Malíková I
Exp Hematol; 2009 Mar; 37(3):386-94. PubMed ID: 19136196
[TBL] [Abstract][Full Text] [Related]
8. Increased cytotoxic T cells with effector phenotype in aplastic anemia and myelodysplasia.
Kook H; Zeng W; Guibin C; Kirby M; Young NS; Maciejewski JP
Exp Hematol; 2001 Nov; 29(11):1270-7. PubMed ID: 11698122
[TBL] [Abstract][Full Text] [Related]
9. Th17 Cells Exhibit Antitumor Effects in MDS Possibly through Augmenting Functions of CD8+ T Cells.
Li J; Yue L; Wang H; Liu C; Liu H; Tao J; Qi W; Wang Y; Zhang W; Fu R; Shao Z
J Immunol Res; 2016; 2016():9404705. PubMed ID: 27722177
[TBL] [Abstract][Full Text] [Related]
10. Immune-mediated bone marrow failure syndromes of progenitor and stem cells: molecular analysis of cytotoxic T cell clones.
Maciejewski JP; O'Keefe C; Gondek L; Tiu R
Folia Histochem Cytobiol; 2007; 45(1):5-14. PubMed ID: 17378239
[TBL] [Abstract][Full Text] [Related]
11. Patients with myelodysplastic syndromes display several T-cell expansions, which are mostly polyclonal in the CD4(+) subset and oligoclonal in the CD8(+) subset.
Fozza C; Contini S; Galleu A; Simula MP; Virdis P; Bonfigli S; Longinotti M
Exp Hematol; 2009 Aug; 37(8):947-55. PubMed ID: 19409953
[TBL] [Abstract][Full Text] [Related]
12. Immune responses to WT1 in patients with AML or MDS after chemotherapy and allogeneic stem cell transplantation.
Casalegno-Garduño R; Schmitt A; Spitschak A; Greiner J; Wang L; Hilgendorf I; Hirt C; Ho AD; Freund M; Schmitt M
Int J Cancer; 2016 Apr; 138(7):1792-801. PubMed ID: 26519872
[TBL] [Abstract][Full Text] [Related]
13. CD8high (CD57+) T cells in normal, healthy individuals specifically suppress the generation of cytotoxic T lymphocytes to Epstein-Barr virus-transformed B cell lines.
Wang EC; Lehner PJ; Graham S; Borysiewicz LK
Eur J Immunol; 1994 Nov; 24(11):2903-9. PubMed ID: 7525311
[TBL] [Abstract][Full Text] [Related]
14. WT1-specific CD8 + cytotoxic T cells with the capacity for antigen-specific expansion accumulate in the bone marrow in MDS.
Suwabe T; Shibasaki Y; Sato H; Tamura S; Katagiri T; Nemoto H; Kasami T; Kozakai T; Nanba A; Kitajima T; Fuse K; Ushiki T; Sone H; Narita M; Masuko M
Int J Hematol; 2021 May; 113(5):723-734. PubMed ID: 33502734
[TBL] [Abstract][Full Text] [Related]
15. A perforin/granzyme-positive MDS-derived T cell line, K2-MDS, induces apoptosis in CD34+ cells through the fractalkine-CX3CR1 system.
Morita Y; Matsuda M; Hanamoto H; Shimada T; Tatsumi Y; Maeda Y; Kanamaru A
Clin Immunol; 2004 Oct; 113(1):109-16. PubMed ID: 15380536
[TBL] [Abstract][Full Text] [Related]
16. Comparison of T lymphocyte subsets in aplastic anemia and hypoplastic myelodysplastic syndromes.
Zhang HF; Huang ZD; Wu XR; Li Q; Yu ZF
Life Sci; 2017 Nov; 189():71-75. PubMed ID: 28935248
[TBL] [Abstract][Full Text] [Related]
17. [Changes and clinical significance of CD8(+) T cell subset in patients with aplastic anemia, myelodysplastic syndrome and acute myeloid leukemia].
Zhang JY; Xu HZ; Yin DM; Feng XM; Sui XH; Cui B; Ma CY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):203-8. PubMed ID: 23484720
[TBL] [Abstract][Full Text] [Related]
18. [Auto- and alloreactivity of T lymphocytes in myelodysplastic syndrome].
Cukrová V; Neuwirtová R; Bartůnková J; Jonásová A; Cermák J; Homolková H; Malíková I
Cas Lek Cesk; 2006; 145(8):647-52; discussion 653. PubMed ID: 16995421
[TBL] [Abstract][Full Text] [Related]
19. Preferential suppression of trisomy 8 compared with normal hematopoietic cell growth by autologous lymphocytes in patients with trisomy 8 myelodysplastic syndrome.
Sloand EM; Mainwaring L; Fuhrer M; Ramkissoon S; Risitano AM; Keyvanafar K; Lu J; Basu A; Barrett AJ; Young NS
Blood; 2005 Aug; 106(3):841-51. PubMed ID: 15827127
[TBL] [Abstract][Full Text] [Related]
20. Generation and ex vivo expansion of cytotoxic T lymphocytes directed toward different types of leukemia or myelodysplastic cells using both HLA-matched and partially matched donors.
Montagna D; Maccario R; Montini E; Tonelli R; Lisini D; Pagani S; Comoli P; Moretta A; Assirelli E; Basso S; Vitiello A; Pession A; Locatelli F
Exp Hematol; 2003 Nov; 31(11):1031-8. PubMed ID: 14585366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
